salmeterol xinafoate has been researched along with Stroke in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chao, HC; Chen, CY; Huang, YB; Lin, PC; Tsai, MJ; Tsai, YH; Yang, CJ | 1 |
| Douglas, I; Grosso, A; Hingorani, AD; Hubbard, R; MacAllister, R; Smeeth, L | 1 |
2 other study(ies) available for salmeterol xinafoate and Stroke
| Article | Year |
|---|---|
Long-acting Inhaled Bronchodilator and Risk of Vascular Events in Patients With Chronic Obstructive Pulmonary Disease in Taiwan Population.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Aged, 80 and over; Bronchodilator Agents; Budesonide, Formoterol Fumarate Drug Combination; Cardiovascular Diseases; Cholinergic Antagonists; Cohort Studies; Delayed-Action Preparations; Drug Combinations; Female; Fluticasone-Salmeterol Drug Combination; Formoterol Fumarate; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Salmeterol Xinafoate; Stroke; Taiwan; Tiotropium Bromide | 2015 |
Inhaled tiotropium bromide and risk of stroke.
Topics: Administration, Inhalation; Aged; Albuterol; Androstadienes; Bronchodilator Agents; Cholinergic Antagonists; Dose-Response Relationship, Drug; Drug Combinations; Female; Fluticasone; Humans; Ipratropium; Male; Middle Aged; Risk Factors; Salmeterol Xinafoate; Scopolamine Derivatives; Stroke; Tiotropium Bromide; United Kingdom | 2009 |